Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
Condition(s):Splenic Marginal Zone LymphomaLast Updated:October 23, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Splenic Marginal Zone LymphomaLast Updated:October 23, 2023Not yet recruiting
Condition(s):Waldenstrom Macroglobulinemia; Lymphoplasmacytic Lymphoma; Monoclonal B-Cell Lymphocytosis; Small Lymphocytic Lymphoma; CLL (Chronic Lymphocytic Leukemia)Last Updated:March 21, 2024Recruiting
Condition(s):Marginal Zone B-cell LymphomaLast Updated:February 1, 2023Completed
Condition(s):Splenic Marginal Zone LymphomaLast Updated:June 7, 2021Completed
Condition(s):Waldenström Macroglobulinemia; Lymphoplasmacytic Lymphoma; Splenic Marginal Zone LymphomaLast Updated:August 19, 2015Completed
Condition(s):Marginal Zone Lymphoma; Nodal Marginal Zone Lymphoma; Splenic Marginal Zone LymphomaLast Updated:May 10, 2023Active, not recruiting
Condition(s):Hairy Cell Leukemia; Splenic Marginal Zone LymphomaLast Updated:August 11, 2017Completed
Condition(s):LymphomaLast Updated:August 26, 2013Completed
Condition(s):Follicular Non-Hodgkin’s Lymphoma; Nodal Marginal Zone Lymphoma; Splenic Marginal Zone LymphomaLast Updated:November 6, 2017Completed
Condition(s):Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Nodal Marginal Zone Lymphoma; Recurrent Splenic Marginal Zone Lymphoma; Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue; Refractory Mantle Cell Lymphoma; Refractory Marginal Zone Lymphoma; Refractory Nodal Marginal Zone Lymphoma; Refractory Splenic Marginal Zone LymphomaLast Updated:March 8, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.